Publications

  • OPDP BULLETINS MARCH 22-28, 2017

    OPDP Notice No. 17043 posted March 22, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – March 2017 OPDP Notice No.17044 ODB Program Payment Dates 2017-18 OPDP Notice No. 17043 posted March 22, 2017 ODB FORMULARY – …

    March 22, 2017
  • OPDP BULLETINS MARCH 15-21, 2017

    OPDP Notice No. 17037 posted March 15, 2017 Prescription Forgery Alert OPDP Notice No. 17038 posted March 16, 2017 Prescription Forgery Alert OPDP Notice No. 17039 posted March 16, 2017 Notice from the Executive Officer: Pan-Canadian Select …

    March 15, 2017
  • OPDP BULLETINS MARCH 1-7, 2017

    OPDP Notice No. 17033 posted March 3, 2017 Prescription Forgery Alert OPDP Notice No. 17034 posted March 3, 2017 Prescription Forgery Alert OPDP Notice No. 17033 posted March 3, 2017 Prescription Forgery Alert Prescription Forgery Alert …

    March 03, 2017
  • eDIRC: NEW! Downloadable Patient Info Sheets

    This content is only available to Association members. Please log in to access this content.

    Learn about becoming a member

    or Sign In

    March 2, 2017, volume 15 no 5

  • OPA Bulletin – February 28, 2017

    This content is only available to Association members. Please log in to access this content.

    Learn about becoming a member

    or Sign In

    • A New Phenomenon in Prescription Refills and Interprofessional Practice
    • March is Pharmacist Awareness Month
    • Who Will Be This Year's Collaborative Service Award Winner?
    • Registration for Conference 2017 Will Open Next Week!
    • Advocacy Roundup
    • Much more

  • OPDP BULLETINS FEBRUARY 22-28, 2017

    OPDP Notice No. 17029 posted February 21, 2017 ODB FORMULARY – EDITION NO. 42, Summary of Changes – February 2017 OPDP Notice No. 17030 posted February 21, 2017 Notice from the Executive Officer: Funding of Hepatitis C drug products …

    February 22, 2017
  • OPDP BULLETINS FEBRUARY 15 - 21, 2017

    OPDP Notice No. 17027 posted February 15, 2017 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program OPDP Notice No. 17027 posted February 15, 2017 Reminder regarding Delisting of …

    February 21, 2017
  • OPA Bulletin – February 21, 2017

    This content is only available to Association members. Please log in to access this content.

    Learn about becoming a member

    or Sign In

    • Help Inform Your Patients About Naloxone - Downloadable Posters Now Available
    • Who Will Be This Year's Achievement in Specialized Practice Award Winner?
    • Participate in the Conference 2017 Student Poster Presentations and Have Your Work Seen by Hundreds of Pharmacy Professionals!
    • Read Our Latest Blog Post: Educating Patients About e-Cigarettes
    • Advocacy Roundup
    • Much more

  • eDIRC: Smoking Cessation & e-Cigarettes: How to Help Your Patients

    This content is only available to Association members. Please log in to access this content.

    Learn about becoming a member

    or Sign In

    February 16, 2017, volume 15 no 4

  • OPDP BULLETINS FRBRUARY 8-14, 2017

    OPDP Notice No. 17025 posted February 08, 2017 Reminder regarding Delisting of High-Strength Long-Acting Opioids under the Ontario Drug Benefit (ODB) Program OPDP Notice No. 17025 posted February 08, 2017 Reminder regarding Delisting of …

    February 14, 2017
Back to top